Abstract
Dihydropyridine Ca channel agonists bear close structural resemblance to several Ca channel antagonists. The most extensively investigated agent in this group is BAY k 8644, first described by Schramm and coworkers. 1−4 Other Ca channel agonists are YC170,5 202–791,6 H 160–51.7 R202–7916 and CGP28–392.8,9 The characteristic property of these agents is to increase the ‘open time’ of the ‘L’ type of calcium channels resulting either in an increase in calcium current during an action potential or during depolarisation by other means.10 The cardiovascular consequence of this is an increase in cardiac contractility and vasoconstriction.2 It is this latter property which has precluded the clinical use of calcium channel agonists in heart failure. However, the calcium channel agonists hold an important place as pharmacological tools. This review will consider some of the anomalous actions of BAY k 8644 which result in “negative” inotropy under certain circumstances. A possible effect of these drugs on sarcoplasmic reticular function, in addition to their better known effect of enhancing trans-sarcolemmal calcium current, will be discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Schramm M, Towart R. Modulation of calcium channels by drugs. Life Sciences 1985;37:1843–1860.
Schramm M, Thomas G, Towart R, Franckowiak G. Novel dihydropyrkJines with positive inotropic actions through activation of Ca channels. Nature 1983;303:535–537.
Schramm M, Towart R, Lamp B, Thomas G. Modulation of calcium ion influx by the 1,4-dihydropyridines nifedipine and BAY k 8644. J Cardiovascular Pharmacology 1985;7:493–496.
Bechern M, Schramm M. Calcium-Agonists. J Molec Cell Cardiol 1987;19 (Suppl II):63–75.
Takenaka T, Maeno H. A new vasoconstrictor 1,4-dihydropyridine derivative, YC-170. Jap J Pharmacol 32:139P.
Hoff RP, Ruegg UT, Hof A, Vogel A. Stereoselectivity at the calcium channel: opposite actions of the enantiomers of a 1,4-dihydropyridine. J Cardiovasc Pharmacol 1985;7:689–693.
Beyer T, Gjorstrup R, Ravens U. Comparison of the cardiac effects of the dihydropyridine-derivative H160/51 with those of the “Ca-agonist” BAY K 8644. Naunyn Schmiedeberg’s Arch Pharmacol 1985;330:142.
Erne P, Burgisser E, Buhler FR, Dubach B, Kuhnis H, Meier M, Rogg H. Enhancement of calcium influx in human platelets by CGP28392, a novel dihydropyridine. Biochem Biophys Res Comm 1984; 118:842–847.
Kokubun S, Reuter H. Dihydropyridine derivatives prolong the open state of Ca channels in cultured cardiac cells. Proc Natl Acad Sci USA 1984;81:482–527.
Hess P, Lansmann JB, Tsien RW. Different modes of calcium channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists. Nature 1984;311:538–544.
Hwang KS, van Breemen C. Effects of the agonist BAY K 8644 on 45Ca-influx and net Ca uptake into rabbit smooth muscle. Eur J Pharmacol 1985;116:299–305.
Salaices M, Marin J, Sanchez-Ferrer CF, Reviriego J. The effects of BAY K 8644 on the contraction of cat middle cerebral and femoral arteries. Biochem Pharmacol 1985;34:3131–3135.
Su CM, Swamy VC, Triggle DJ. Calcium channel activation in vascular smooth muscle by BAY K 8644. Can J Physiol Pharmacol 1984;62:1401–1410.
Thomas G, Chung M, Cohen CJ. A dihydropyridine (BAY K 8644) that enhances calcium currents in guinea pig and calf myocardial cells. A new type of positive inotropic agent. Circ Res 1985;56:87–96.
Sanguinetti MC, Kass RS. Regulation of cardiac calcium channel current and contractile activity by the dihydropyridine BAY K 8644 is voltage-dependent. J Mol Cell Cardiol 1984;16:667–670.
Koch-Weser J, Blinks JR. The influence of the interval between beats on myocardial contractility. Pharmacol Rev 1963;15:601–652.
Bose D, Chau T, Hryshko LV, King BW. Mechanism of interval-force relation in canine ventricular myocardium studied with ryanodine. Brit J Pharmacol in press.
Bers DM. Ca influx and sarcoplasmic reticulum Ca release in cardiac muscle activation during post-rest recovery. Am J Physiol 1985;248:H366–H381.
Hryshko LV, Bose D. Impairment of Ca release from mammalian ventricular sarcoplasmic reticulum by the calcium channel agonist BAY K 8644. Brit J Pharmacol 1988;94:291–292.
Saha JK, Hryshko LV, Bouchard RA, Chau T, Bose D. Analysis of the effects of (−) and (+)isomers of the 1,4-dihydropyridine calcium channel agonist, BAY k 8644 on post-rest potentiation in the canine ventricular muscle. Can J Physiol Pharmacol in press.
Sutko JL, Willerson U, Templeton GH, Jones LR, Besch HR Jr. Ryanodine: its alteration of cat papillary muscle contractile state and responsiveness to inotropic interventions and a suggested mechanism of action. J Pharm exp Ther 1979;209:37–47
Morad M, Goldman Y. Excitation-contraction coupling in heart muscle: membrane control of development of tension. Prog Biophys Molec Biol 1973;27:257–313.
Wohlfart B, Noble MIM. The cardiac excitation-contraction cycle. Pharmac Ther 1982;16:1–43.
Schouten VJA, van Deen JK, de Tombe P, Verveen AA. Force-interval relationship in heart muscle of mammals. A calcium compartment model. Biophys J 1987;51:13–26.
Lewartowski B, Prokopczuk A, Pytokowski B. Effect of inhibitors of slow calcium current on rested state contraction of papillary muscle and post-rest contractions of atrial muscle of the cat and rabbit hearts. Pflugers Arch 1978;377:167–175.
Lin CI, Vassalle M. Effect of calcium on strophanthidin-induced electrical and mechanical toxicity in cardiac Purkinje fibers. Can J Physiol Pharmacol 1983;61:1329–1339.
Bose D, Kobayashi T, Hryshko LV, Chau T. Depression of canine ventricular sarcoplasmic reticulum by the calcium channel agonist, BAY k 8644. In Heart Function and Metabolism, Ed. Dhalla NS, Pierce GN, Beamish RE, Pub. M. Nijhoff Publishing, Boston, 1987, pp 207–220.
Lappe DL, Lakatta EG. Intensity fluctuation spectroscopy monitors contractile activation in ‘resting’ cardiac muscle. Science 1980;207:1369–1371.
Lakatta EG, Lappe DL Diastolic scattered light intensity fluctuation, resting force and twitch force in mammalian cardiac muscle. J Physiol (Lond) 1981;315:369–394.
Kort AA, Lakatta EG. Calcium-dependent mechanical oscillation occur spontaneously in unstimulated mammalian cardiac tissues. Circ Res 1984;54:396–404.
Bose D, Kobayashi T, Bouchard RA, Hryshko LV. Scattered light intensity fluctuation in the canine ventricular myocardium: Correlation with inotropic drug effect. Can J Physiol Pharmacol in press.
Kurihara S, Sakai T. Effects of rapid cooling on mechanical and electrical responses in ventricular muscle of guinea-pig. J Physiol (Lond) 1985;361:361–378.
Bridge JHB. Relationships between the sarcoplasmic reticulum and sarcolemmal calcium transport revealed by rapidly cooling ventricular muscle. J Gen Physiol 1986;88:437–473.
Sutko JL, Bers DM, Reeves JP. Postrest inotropy in rabbit ventricle: Na-Ca exchange determines sarcoplasmic reticulum Ca content. Am J Physiol 1986;250:H654–661.
Bouchard R, Hryshko LV, Saha JK, Bose D. Effect of caffeine or ryanodine on the Inhibition of rest potentiation In canine ventricular trabecula by BAY k 8644. Fed Proc 2:4867 Abs.
Thomas G, Grob R, Ritzer G, Ruegg JC. The positive inotropic dihydropyridine BAY K 8644 does not affect calcium sensitivity or calcium release of skinned cardiac fibers. Naunyn-Schmiedeberg’s Arch Pharmakol 1985;328:378–381.
Zorzato F Volpe P, Salviati G, Margreth A. Ca2+ channel agonist BAY K 8644 does not elicit Ca release from skeletal muscle sarcoplasmic reticulum. FEBS 1985;186:255–258.
Sommer JR, Johnson EA. Ultrastructure of cardiac muscle. In Handbook of Physiology, Section 2. The Cardiovascular System, Vol. 1. The Heart, ed. Berne RM, Sperelakis N. 1979, pp. 113–186. Washington, D.C.: American Physiol Pub.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers
About this chapter
Cite this chapter
Bose, D., Hryshko, L.V., Saha, J.K., Bouchard, R.A., Chau, T. (1989). The Action of Calcium Channel Agonists on the Mammalian Ventricular Myocardium. In: Anand, I.S., Wahi, P.L., Dhalla, N.S. (eds) Pathophysiology and Pharmacology of Heart Disease. Developments in Cardiovascular Medicine, vol 102. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1607-7_6
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1607-7_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8889-3
Online ISBN: 978-1-4613-1607-7
eBook Packages: Springer Book Archive